Year: 2025
Type: article
Abstract: The pharmaceutical laboratory informatics landscape is experiencing a fundamental shift from traditional on-premises systems to Software-as-a-Service (SaaS) solutions. This paradigm transformation addresses longstanding challenges of capital-intensive infrastructure, operational inefficiencies, and resource-intensive maintenance cycles. SaaS platforms offer pharmaceutical organizations distinct advantages including reduced financial barriers, improved operational continuity, streamlined compliance, enhanced security frameworks, and greater workflow flexibility. The evolution from early mainframe laboratory systems to modern cloud architectures reflects broader digital transformation trends, albeit with delayed adoption in pharmaceutical environments due to stringent regulatory requirements and data integrity concerns. As cloud technologies mature to address industry-specific needs, pharmaceutical organizations increasingly recognize SaaS implementation benefits across research, development, manufacturing, and quality control functions. Successful implementation strategies incorporate comprehensive readiness assessments, structured migration pathways, and robust change management methodologies addressing both technical and human factors throughout the transition process.
Author: Venkatesan Kannan
Institutions: Cognizant (United States), Cognizant (India)
Language: English
Subfield: Information Systems
Field: Computer Science
Domain: Physical Sciences
Open Access status: hybrid
OpenAlex ID: W4411467078